Article thumbnail

Ascorbic acid has superior antiviral and antiproliferative effects over IFN-alpha in HAM/TSP PBMC ex vivo

By Britta Moens, Daniele Decanine, Ricardo Khouri, Giovanni Lopez, Michael Talledo, Eduardo Gotuzzo, Françoise Bex, Bernardo Galvão Castro, Anne-Mieke Vandamme and Johan Van Weyenbergh
Topics: Meeting Abstract
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3112776
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2011). britta.moens@rega.kuleuven.be 1Laboratory of Clinical and Epidemiological Virology, Rega Institute for Medical Research K.U. Leuven, Leuven, Belgium Full list of author information is available at the end of the article Moens et al.
  2. (1996). Osame M: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.